CLDN1 and colorectal cancer: Some studies have suggested that it inhibits the translation of claudin-1, claudin-3, jam-1, and occludin in intestinal barrier tight junction proteins, reduce their stability, and lead to intestinal mechanical barrier dysfunction and promote the progression of colorectal cancer [59].